Anne Pernille Ofstad
9PUBLICATIONS
28CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jul 14, 2023
Baseline Cardiovascular Risk Factor Control in Patients With Type 2 Diabetes and Coronary Disease Versus Stroke: Secondary Analysis of Cardiovascular Outcome Trials.Priyadarshini Balasubramanian, Walter N Kernan, Kevin N Sheth
|May 30, 2023
Development of a tool to predict the risk of incident heart failure in a general population: the HUNT for HF risk score.Anne Pernille Ofstad, Cathrine Brunborg, Odd Erik Johansen
|Jan 26, 2023
Cardiovascular outcomes trial data from EMPA-REG OUTCOME, CAROLINA and CARMELINA: Assessment of a novel staging system for type 2 diabetes.Moahad S Dar, Christoph Wanner, Nikolaus Marx
|Jun 28, 2022
Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes.Gerasimos Filippatos, Javed Butler, Dimitrios Farmakis
|Feb 15, 2022
Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomes.Sabine Kahl, Anne Pernille Ofstad, Bernard Zinman
|Apr 01, 2020
Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA-REG OUTCOME trial.Subodh Verma, Abhinav Sharma, Bernard Zinman
Pageof 2
Frequent Collaborators
3 joint publications
Bernard Zinman
2 joint publications
Subodh Verma
2 joint publications
David Fitchett
2 joint publications
Javed Butler
2 joint publications
Christoph Wanner
2 joint publications
Silvio E Inzucchi
1 joint publications
Christine Sommer
1 joint publications
Qiuhe Ji
1 joint publications
Abhinav Sharma
1 joint publications
Sabine Kahl
